Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate vs Fixed-Combination in Post-Cataract Surgery Inflammation
NCT04631315Phase 4Completed
- Sponsor
- Laboratorios Poen
- Start
- Mar 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of difluprednate in inflammation, sponsored by Laboratorios Poen. Started Mar 2019; status: completed.
02
Drugs
difluprednate
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT04631315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631315.